Published by ChinaMNC · Qiubei
Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Materials: What Foreign Founders Need to Know
Yunnan Province has released a plan to reshape its traditional Chinese medicine (TCM) material industry by 2030, focusing on quality, processing, and branding. For foreign founders in China's health and wellness sector, this presents both opportunities and regulatory considerations. Here's a concise overview of the plan's key points and practical implications.
Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Materials
Foreign founders operating in China's health, wellness, or pharmaceutical sectors should note that Yunnan Province has issued a development plan for its traditional Chinese medicine (TCM) material industry through 2030. The plan, published by the Yunnan Provincial People's Government, aims to shift the industry from volume-based growth to quality-driven development. Below is a summary of the plan's targets and measures, framed for foreign entrepreneurs considering or already running a business in China.
Key Targets by 2030
According to the plan, Yunnan expects to reduce the area dedicated to TCM material cultivation by 1.608 million mu (approximately 107,200 hectares) while increasing the comprehensive output value by 50 billion RMB. This strategic reduction is intended to improve quality, processing, branding, and overall efficiency.
Optimizing Variety Layout
Building on the 156 varieties listed in the 2024 edition of Yunnan's Dao-di Herbs Catalogue, the plan prioritizes three categories:
- Dao-di advantage varieties: The "Top Ten Yun Medicines," represented by Panax notoginseng (sanqi), along with others such as Paris polyphylla (chonglou), Erigeron breviscapus (dengzhanhua), Dendrobium officinale (tiepi shihu), Amomum villosum (sharen), Gastrodia elata (tianma), Poria cocos (yun fuling), Angelica sinensis (yun danggui), Aucklandia lappa (yun muxiang), and Gentiana rigescens (dian longdan).
- Health characteristic varieties: The "Top Ten Health Resources," including Polygonatum kingianum (dian huangjing), Carthamus tinctorius (honghua), Bletilla striata (baiji), Dendrobium devonianum (zipi shihu), Phyllanthus emblica (yu gan zi or dian ganlan), Coix lacryma-jobi (yiyiren), Terminalia chebula (hezi), Amomum tsaoko (caoguo), ginger, and star anise.
- Potential cultivation varieties: The "Six Southern Medicines," such as Amomum villosum (sharen), Dragon's blood (longxuejie), Cibotium barometz (gouji), Aquilaria sinensis (chenxiang), Orthosiphon aristatus (shencha), and Dai bai jie.
Accelerating Standardized Construction
The plan aims to establish 200 GAP (Good Agricultural Practice) bases for TCM materials. A key focus is achieving full GAP coverage for Wenshan sanqi, while orderly promoting GAP bases for under-forest varieties like Poria cocos (fuling), Amomum villosum (sharen), Amomum tsaoko (caoguo), and Phellodendron chinense (huangbo). Additionally, the province seeks to develop a number of national-level high-standard TCM material raw material production bases.
Under-Forest Cultivation and Breeding
Focusing on Dao-di herbs such as sanqi, tianma, fuling, sharen, huangjing, and huangbo, the plan promotes under-forest cultivation and breeding. The area for ecological and under-forest planting bases is targeted to expand to over 6 million mu (approximately 400,000 hectares).
Primary Processing at Origin
The plan supports the establishment of processing lines at production sites in Dao-di herb-producing areas and high-standard raw material bases. It encourages linking GAP base materials with fresh-cut processing and upgrading products from primary raw materials to semi-industrialized inputs.
Developing High Value-Added Products
Enterprises are encouraged to build modern deep-processing production lines and develop high value-added products, forming a series of Yun Medicine health products. The plan also promotes R&D and industrialization of health products in areas such as daily cosmetics and functional wellness.
Preventing Blind Expansion and Stabilizing the Market
For bulk varieties susceptible to market fluctuations, such as sanqi, danggui, and chonglou, and for scarce varieties, the plan proposes market-based adjustment mechanisms to smooth price swings. An information monitoring and early-warning system will be established to guard against risks like "blind expansion" and "falling prices hurting farmers."
Food-Medicine Homology Development
The plan includes developing standards for food-medicine homology raw materials, production and processing specifications, and related series. It aims to complete cross-border registration of 5–10 new products and plans to organize a "Yun Medicine Food-Medicine Homology Culture Festival."
"Yun Medicine Brain" AI Project
An artificial intelligence innovation application project called "Yun Medicine Brain" will be implemented, building an intelligent application system covering the entire life cycle of TCM materials. The focus is on forming multi-level, multi-scenario intelligent solutions in key areas of TCM materials.
Practical Implications for Foreign Founders
For foreign entrepreneurs, these measures signal a shift toward higher quality and standardized production in Yunnan's TCM material sector. Opportunities may arise in GAP base development, deep processing, health product R&D, and cross-border registration of food-medicine homology products. However, founders should be aware of the regulatory emphasis on GAP compliance, quality standards, and market stabilization mechanisms. Engaging with local authorities and understanding the specific requirements for GAP bases and product registration will be essential.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.
Next Steps
Foreign founders interested in exploring opportunities in Yunnan's TCM material industry or needing assistance with company registration and operations in China can contact ChinaMNC via WhatsApp or WeChat at +86 153 1898 8535.